Home›Articles›Radotinib: a Korean development path and a limited approvalArticleRadotinib: a Korean development path and a limited approvalArticlesConnectionsSourcesComments (0)Reader Challenges (0)ConnectionsArticle OnRadotinib, Drugs and Medicinal Substances Well-attested SourcesRadotinib (Wikipedia)Clinical trialsQuote, Clinical trialsIn 2011, Il-Yang initiated a Phase III, multinational, randomized study comparing radotinib with imatinib as first-line therapyView the SourceMedicine Atlas Original Articlestier 1Comments (0)No comments yet. Be the first to share a thought.Sign in to join the discussion.Reader Challenges (0)No disputes yet. Spotted an error or a better source? Open the first one.Sign in to dispute this or suggest a correction.